PRESS RELEASE

[News] BioPlus’ filler and anti-adhesion agent approved by the UK’s Medicines and Healthcare Product Regulation Agency (MHRA).

By 2021년 May 18일July 23rd, 2021No Comments

Our Filler products and anti-adhesion products have been approved and registered by MHRA in the United Kingdom.

In accordance with the recent Brexit policy of the United Kingdom, exports to the United Kingdom can be made only with the permission of the British government, apart from CE recognized by the European Union.

As of 14 May 2021, the UK’s Medicines and Healthcare Product Regulation Agency (MHRA) approved the approval of BioPlus’s two products (Filler and Anti-Adhesion Drugs).

As a result, our company has been approved by the United Kingdom (MHRA) in addition to the previously approved European Union (CE), the United States, Canada, Australia, Brazil and Japan (MDSAP), and has been greatly encouraged by exports to major Western developed countries

bioplubiz

Author bioplubiz

More posts by bioplubiz

Leave a Reply